The mechanism of tolerance to arsenic toxicity is not known. Recently
it has been shown that arsenic induces metallothionein (MT), which is
a sulfhydryl-rich, metal-binding protein that decreases the toxicity o
f a number of metals. The present studies were designed to examine the
role of MT in arsenic toxicity. Zinc (Zn) pretreatment (1000 mu mol/k
g, sc) markedly increased hepatic MT (150-fold over controls), and als
o protected against the lethal effects of arsenite (130 mu mol/kg, sc)
. However, no correlation was found between the ability of various kno
wn MT inducers (Zn, Cd, arsenite, monomethylarsenite, alpha-hederin, o
r oleanolic acid) to increase hepatic MT and to protect against arseni
c lethality in mice. To examine the mechanism of Zn protection against
arsenic toxicity, the subcellular distribution of arsenite in liver,
kidney, and small intestine was determined 2 hr after arsenite injecti
on. Zn pretreatment did not markedly alter the amount of arsenic-73 in
the cytosol or the various cellular organelles (nuclei, mitochondria,
microsomes) in liver, kidney, or small intestine. There was also very
little arsenic-73 bound to MT in the cytosol of the Zn-pretreated mic
e, as determined by G-75 gel-filtration chromatography. In mice pretre
ated with Zn (1000 mu mol/kg, sc) and subsequently injected with arsen
ite-73 (115 mu mol/kg, sc), the arsenic-73 content in blood, heart, lu
ng, kidneys, spleen, muscle, and skin was lower than in controls, indi
cating increased arsenic elimination in Zn-pretreated mice. In conclus
ion, Zn pretreatment protects mice against arsenite toxicity, but the
mechanism of tolerance does not appear to be induction of MT. (C) 1994
Society of Toxicology.